Biotechnology company pioneering mRNA medicines
Mission: To deliver on the promise of mRNA science to create a new generation of transformative medicines for patients.
Founded
2010
Headquarters
Cambridge, MA
Employees
5,000-10,000
Industry
Biotechnology
Revenue
6-7 Billion USD
Funding
Public (NASDAQ: MRNA)
CEO
Stéphane Bancel
Website
modernatx.com
Opportunity to work on cutting-edge, life-saving mRNA technology.
Career GrowthCompetitive compensation and benefits packages.
CompensationFast-paced, innovative work environment with high impact.
Company CultureHigh-pressure environment due to rapid development timelines.
Work-Life BalanceOrganizational changes can occur frequently as the company pivots priorities.
StabilityAdd anonymous, community-submitted insights for this company section.
Loading contributions...